BRIEF published on 12/15/2025 at 16:47, 3 months 10 days ago Vitruvia Medical AG Strengthens Financial Structure Through Capital Increase Financial Structure Capital Increase Debt Reduction Convertible Bond Vitruvia Medical AG
PRESS RELEASE published on 12/15/2025 at 16:42, 3 months 10 days ago EQS-Adhoc: Vitruvia Medical AG: successfull capital increase and strengthening of the financial structure Vitruvia Medical AG successfully completes capital increase, strengthens financial structure, and improves long-term financing and economic stability Financial Structure Capital Increase Long-term Financing Economic Stability Vitruvia Medical AG
BRIEF published on 08/01/2025 at 08:30, 7 months 25 days ago Vitruvia Medical AG Reports Half-Year Results for 2025 Half-year Results Consolidated Sales Net Loss Vitruvia Medical AG 2025 Financial Report
PRESS RELEASE published on 08/01/2025 at 08:25, 7 months 25 days ago EQS-Adhoc: Vitruvia Medical AG: Half yearly results as per June 30, 2025 Vitruvia Medical AG reports half-year results as of June 30, 2025 in line with expectations, confirming full-year forecast. Anticipates sales growth and earnings improvement Sales Growth Forecast Half-year Results Earnings Improvement Vitruvia Medical AG
BRIEF published on 05/03/2025 at 08:02, 10 months 23 days ago Vitruvia Medical AG Reports Financial Results for 2024 Revenue Growth Future Outlook Vitruvia Medical AG 2024 Annual Results Improved Earnings
PRESS RELEASE published on 05/03/2025 at 07:57, 10 months 23 days ago EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31,2024 Vitruvia Medical AG reports 2024 Year End results, with increased revenue and EBITA. Positive outlook for 2025. Details in press release Revenue 2024 Vitruvia Medical AG Year End Results EBITA
BRIEF published on 07/25/2024 at 22:03, 1 year 8 months ago Vitruvia Medical AG: Half-Year Results as of June 30, 2024 Financial Performance Half-year Results 2024 Forecast Sales Targets Vitruvia Medical AG
PRESS RELEASE published on 07/25/2024 at 21:58, 1 year 8 months ago EQS-Adhoc: Vitruvia Medical AG: Half yearly results as per June 30th, 2024 Vitruvia Medical AG reports half-year results in line with expectations for the first half of 2024, confirming full-year forecast. Positive outlook with expected sales around EUR 2.0 million Sales Forecast Earnings Half-year Results Vitruvia Medical AG
BRIEF published on 05/01/2024 at 08:41, 1 year 10 months ago Vitruvia Medical AG Announces Improved Year-End Financial Results for 2023 Financial Results Revenue Growth 2024 Outlook Vitruvia Medical AG EBITA Improvement
PRESS RELEASE published on 05/01/2024 at 08:36, 1 year 10 months ago EQS-Adhoc: Vitruvia Medical AG: Year End results as of December 31, 2023 Vitruvia Medical AG reports Year End results for 2023 with revenue and earnings growth. Financial performance overview and outlook for LT technologies for 2024 Revenue Growth Financial Performance Vitruvia Medical AG Year End Results LT Technologies
Published on 03/26/2026 at 11:07, 24 minutes ago U.S. Mined and Refined Metals as well as Rare Earth Elements to Be Tokenized in Historic American Strategic Minerals and Datavault AI Deal
Published on 03/26/2026 at 11:00, 31 minutes ago Stagwell Expands the Harris Poll's Harrisquest Across Europe
Published on 03/26/2026 at 08:05, 3 hours 26 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 6 hours 36 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 11:03, 28 minutes ago EQS-Adhoc: VIDINEXT AG: Marketing agreement with Telekom Deutschland GmbH
Published on 03/26/2026 at 11:00, 31 minutes ago Genel Energy PLC: Posting of Annual Report and Notice of AGM
Published on 03/26/2026 at 11:00, 31 minutes ago Genel Energy PLC: Report on payments to governments for the year 2025
Published on 03/26/2026 at 11:00, 31 minutes ago ABB Ltd: ABB share buybacks - March 19, 2026 - March 25, 2026
Published on 03/26/2026 at 11:00, 31 minutes ago Independent study reveals 44% ROI with EQS Compliance Cockpit and payback in under six months
Published on 03/26/2026 at 07:30, 4 hours 1 minute ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 17 hours ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 17 hours 46 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
